Regulatory Approval

2nd February 2010


                           ECO Animal Health Group plc

ECO RECEIVES REGISTRATION APPROVAL FOR COMPANION ANIMAL PRODUCT IN LATIN AMERICA

ECO Animal Health Group plc is pleased to announce that its subsidiary ECO
Animal Health (ECO) has been granted a marketing authorisation in Mexico for
Ecoheart Chewable Tablets for dogs.

Ecoheart Chewable Tablets is the first companion animal product for which ECO
has received a marketing authorisation in Latin America where the  pet sector is
an important and growing market. Further marketing authorisations in the key
markets of the region are expected.

Ecoheart Chewable Tablets prevent heartworm disease and are also effective in
the treatment and control of roundworms and hookworms in dogs. Canine heartworm
infection is transmitted by mosquitoes. It is potentially fatal and requires a
monthly preventative treatment.

Peter Lawrence, Chairman of ECO Animal Health Group plc, commented:
" We are delighted to add this Ecoheart approval to our Ecomectin range of
endectocides,  where it is already licensed for sale in Japan. Heartworm can be
an unpleasant killer of dogs especially in warmer climates when left untreated
.This is a further important registration for the company's portfolio of
specialised drugs for animals"


Contacts:
ECO Animal Health Group plc             Peter Lawrence 020 8336 2900

Spiro Financial      Anthony Spiro      020 8336 6196

Cenkos Securities plc                   Stephen Keys   020 7397 8926
(Nominated Adviser)

ECO  Animal  Health Group plc is a leader in the development,  registration  and
marketing  of  pharmaceutical products. Our products  for  these  global  growth
markets  promote well being in animals. Our financial goals are achieved through
the  careful  and responsible application of science to generate value  for  our
shareholders.